TAKEDA PHARMACEUTICAL CO LTD

Tokyo, M0 · CIK 1395064 · 13F filing filed 2025-11-13

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$16.4m reported value -16.3% vs Q2 2025

8positions

100.0%in top 10

0 new 1 added 0 reduced 3 sold out vs Q2 2025

This report includes the holdings of 1 other manager that shares the investment decisions:

Takeda Vaccines, Inc. – reports through this filing

Shares in two reports are counted once in each security's totals.

Holdings, Q3 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#	Security	Ticker	Shares	Value	% of portfolio	Change	Shares change
1	OVID THERAPEUTICS INC COM OVID	OVID	7,531,996	$9.8m59.82%	59.82%	Unchanged
2	EQUILLIUM INC COM EQ	EQ	1,824,977	$2.6m15.94%	15.94%	Unchanged
3	XILIO THERAPEUTICS INC COM COM		1,475,121	$1.2m7.59%	7.59%	Unchanged
4	SHATTUCK LABS INC COM STTK	STTK	515,619	$1.2m7.53%	7.53%	Unchanged
5	LYELL IMMUNOPHARMA INC COM COM		54,887	$891.4k5.45%	5.45%	Added +13.7k	+13,722 33.3%
6	AMERICAN WELL CORP COM CL A NEW AMWL	AMWL	77,733	$478.1k2.92%	2.92%	Unchanged
7	RANI THERAPEUTICS HLDGS INC COM CL A RANI	RANI	203,190	$101.6k0.62%	0.62%	Unchanged
8	STANDARD BIOTOOLS INC COM LAB	LAB	16,515	$21.5k0.13%	0.13%	Unchanged

Sold out since Q2 2025

Security	Shares held before	Value then
HILLEVAX INC	6,724,000	$13.4m6.7m shares
TURNSTONE BIOLOGICS CORP	895,824	$321.6k895.8k shares
THIRD HARMONIC BIO INC	36,835	$200.0k36.8k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

Company	Ticker	Stake	Change	Schedule	Last filed
OVID THERAPEUTICS INC OVID · 13G · filed 2025-12-09	OVID	12.3%≈ $23.6m		13G	2025-12-09